Medidata Medidata

NEXT Paris Conference

Medidata NEXT Paris Conference Logo

Medidata NEXT

31st March 2020 l 8am-6:30pm

At Pavillon D’Armenonville, Paris

About the Event

Join Medidata at our exclusive clinical research conference in Paris! With the region’s life sciences landscape evolving at a rapid pace, staying ahead of regulatory and market developments means embracing true innovation. Medidata NEXT drives forward-thinking conversations, highlights influential voices, and ultimately, spurs real action to improve patient lives.

We invite you to participate in the conversations driving industry trends while experiencing the latest technology on the Medidata and Dassault Systèmes platforms. You will network with a distinct audience of tech adopters, decision-makers, and trial trendsetters.

The conference is free to attend for our customers and qualified members of the life sciences ecosystem. Space is limited — claim your seat today!

Agenda

8am | Registration & Breakfast

9am | Welcome

Host: Christian Hebenstreit, General Manager & Senior Vice President EMEA, and Karim Herbal, PhD, Senior Director, Sales EMEA, Medidata Solutions

9:10am | Life Sciences and Clinical Trial Developments Overview

Speaker: Glen de Vries, President and Co-founder, Medidata Solutions

10:30am | Introduction to the 3DS Ecosystem

Speaker: Patrick Johnson, VP Corporate Science and Research, Dassault Systèmes

10:45am | Coffee Break & Networking

11:15am | Industry Case Study

Speaker: Fabrice André, MD, PhD, Researcher, and Chairman of the Biomarker Group at UNICANCER

11:45am | Patient Advocate Session

12:30pm | Lunch & Networking

1:30pm | Breakout Sessions

NEXT 2020 will inspire you with the latest innovations and thinking to unlock the power of data for successful, effective clinical trials. You’ll learn how industry-tested solutions from Medidata and our partners have solved some of the most pressing challenges facing our industry. Whether you’re a Medidata platform power user or just beginning your first study, you’ll gain more insights during our three deep-dive afternoon tracks, with breakout sessions covering:

Track 1 | Best practices for today’s clinical trial: The clinical development and drug approval ecosystem is changing with historic velocity, and new models and strategies are needed to improve the likelihood of approval. What does success take? Data capture, management, and clinical operations with a unified platform.

Track 2 | Data analytics: With its exponential growth, centralized, integrated data drives the insights that boost the value of a study. What does it take to succeed? A different way of thinking and working, one which connects the life science ecosystem on a single operating system. A unified system delivers a central clinical and commercial source of truth for data; simple and easy to use tools for workflow collaborations; and artificial intelligence driven insights.

Track 3 | Empowering Patients: At the center of every clinical trial is the patient, and the quality of the patient experience has real-world implications for the discovery of new therapies. Understanding how to optimize the patient experience drives real value in the development of new drugs and medical devices.

5:15pm | Networking Drinks

Best practices for today’s clinical trial: The clinical development and drug approval ecosystem is changing with historic velocity, and new models and strategies are needed to improve the likelihood of approval. What does success take? Data capture, management, and clinical operations with a unified platform.

1:30pm | Breakout Sessions

3pm | Coffee Break & Networking

3:30pm | Breakout Sessions

Data analytics: With its exponential growth, centralized, integrated data drives the insights that boost the value of a study. What does it take to succeed? A different way of thinking and working, one which connects the life science ecosystem on a single operating system. A unified system delivers a central clinical and commercial source of truth for data; simple and easy to use tools for workflow collaborations; and artificial intelligence driven insights.

1:30pm | Breakout Sessions

3pm | Coffee Break & Networking

3:30pm | Breakout Sessions

Empowering Patients: At the center of every clinical trial is the patient, and the quality of the patient experience has real-world implications for the discovery of new therapies. Understanding how to optimize the patient experience drives real value in the development of new drugs and medical devices.

1:30pm | Breakout Sessions

3pm | Coffee Break & Networking

3:30pm | Breakout Sessions

Hosts & Keynote Speakers

Glen de Vries
Co-Founder, Co-CEO

Glen is the co-CEO and co-founder of Medidata Solutions, the leading cloud platform for life sciences research. Glen has been driving Medidata's mission since the company’s inception in 1999: Powering smarter treatments and healthier people. His publications have appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, STAT, Urologic Clinics of North America and TechCrunch. He is a trustee of Carnegie Mellon University, a Columbia HITLAB Fellow, and a member of the Healthcare Businesswomen’s Association European Advisory Board.

Glen received his undergraduate degree in molecular biology and genetics from Carnegie Mellon University, worked as a research scientist at the Columbia Presbyterian Medical Center and studied computer science at New York University's Courant Institute of Mathematics.

You can follow Glen on Twitter at @CaptainClinical.

Patrick Johnson
VP Corporate Science & Research at Dassault Systèmes

Patrick Johnson is VP Corporate Science & Research at Dassault Systèmes. His mission is to define the scientific bases of the company’s solutions, invent new disruptive technologies for the Industry Renaissance and animate the group’s global research ecosystem.

After joining in 1996, he held various positions in R&D, from Product Lifecycle Management infrastructure to virtual product design solutions for the CATIA flagship brand. In 2001, he became head of the artificial intelligence department and played an instrumental role with new engineering practices currently now adopted in multiple sectors, such as smart morphing templates, and industrial processes capitalization & reuse automation.

As Head of Corporate Research in 2004, he launched the development of original technologies for all brands, and significantly grew the global innovation ecosystem of public/private partnerships with prestigious research bodies. In addition, he launched a strategic diversification for 3DS, following a very large European research program (BioIntelligence), resulting in a suite of collaborative applications for the life sciences sector, and the creation of the BIOVIA brand with a worldwide R&D lab in modeling, simulation, big data for life sciences.

A graduate of ENSAE, Mr. Johnson is based at 3DS Headquarters near Paris. He is or has been a member of the National Academy of Technology as well as of the scientific boards of INRIA, and International Society of Computational Biology.

Christian Hebenstreit
SVP, EMEA Region

Christian brings more than 20 years of operational and commercial experience across multiple sectors to his role at Medidata. As managing director of EMEA (Europe, the Middle East and Africa), he plays an integral role in the development and execution of the Company’s overall growth strategy and success within the EMEA market.

Christian joins Medidata from Salesforce.com, where he was the regional vice president for Central Europe. During his tenure, he established and expanded EMEA operations for a number of high-profile companies, and was recognized as the “Worldwide Salesforce VP of the Year” in 2014. Prior to Salesforce, Christian spent seven years at Oracle Corporation, where he initially led the strategic accounts group for EMEA’s largest customers and later became the lead for business analytics in Germany. He has also held roles at IBM and Arthur Andersen Business Consulting.

Christian received his MBA from Germany’s Westfälische Wilhelms-Universität Münster and completed continuing education programs at London Business School, INSEAD and Henley Management College.

Fabrice André, MD, PhD
Researcher, Chairman of the biomarker group at UNICANCER

Fabrice André, MD, PhD, received his MD in Grenoble in 2002, and a PhD in Biotechnology from Paris University in 2005.

He is a past recipient of Young Investigator and Career Development awards from the American Society of Clinical Oncology (ASCO) and is currently Professor in the Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.

His research work in the field of biomarkers and personalised therapies focuses on biomarker discovery, development of targeted agents and implementation of personalised medicine. His team includes 70 people working on basic sciences, bioinformatics, biotechnologies and clinical research. He is also leading phase I-III trials testing targeted agents in the field of breast cancer and large national trials testing implementation of high throughput technologies in the health care system.

Professor André has published more than 200 peer-reviewed papers, including papers in the New England Journal of Medicine, Lancet, Nature Medicine, Science, Lancet Oncology and Journal of Clinical Oncology, either as main or co-author.

Professor André is chairman of the biomarker group at UNICANCER (French cooperative group) and was a member of several scientific committees for international meetings, including SABCS, AACR, ECCO, ESMO, and IMPAKT.

Professor André has been a member of the Annals of Oncology Editorial Board (2010-2013), Associate Editor since 2014 and in September 2017 became Editor-in-Chief.

He has been a member of the ESMO Educational Committee since 2009, he was coordinator (2012-2014) and member (since 2015) of the ESMO Breast Cancer Faculty. Professor André was also a member of the ESMO Cancer Research Faculty, 2012-2014; and is currently chair of the ESMO Translational Research and Precision Medicine Working Group.

The Venue

Pavillon d'Armenonville

Allée de Longchamp, 75116, Paris, France

Pavillon d’Armenonville is located at the edge of Bois de Boulogne, just a few minutes from Porte Maillot and the Champs-Elysées.

About Medidata Next

Medidata NEXT is a global experience that unites more than 3,000 professionals in Life Sciences across a series of events in Europe, North America, and Asia.

NEXT Paris is a fantastic opportunity to stay on the cutting edge of clinical development, as the industry undergoes exciting changes and propels us into the future.

“Medidata NEXT brings together a variety of people from all across the industry, but we’re all singularly focused on one mission, to improve patient lives and patient experiences.”

— Senior Manager from Accenture

We look forward to seeing you in Paris.